CD22 and breast carcinoma: A comprehensive examination of breast cancer cell lines (BT549, MDA-MB-231, MCF7) for expression of CD22 by WB and IF staining, followed by IHC staining of 97 TNBC specimens, showed that CD22 is widely expressed in the cytoplasm and cell membrane of TNBC cells.